The Japanese Yen (JPY) fell to a two-week low against the US Dollar (USD), with the USD/JPY pair trading just below the 158.50 level during the Asian session on Friday. This marks the fifth consecutive day of gains for the pair, as the US Dollar remains broadly firm and on track for strong weekly gains [1]. The move was driven by traders increasing their bets on a US Federal Reserve interest rate hike in 2026, following hotter-than-expected US inflation data released earlier in the week. Additionally, US Retail Sales expanded for the third straight month in April, signaling robust consumer spending and reinforcing hawkish expectations for the Fed [1].
Geopolitical factors also played a role, with ongoing uncertainties such as stalled US-Iran peace talks and persistent tensions in the Middle East. Meanwhile, US-China relations have stabilized after a high-level summit between President Donald Trump and President Xi Jinping, an event welcomed by the International Monetary Fund (IMF) for its potential to reduce global economic uncertainty [1].
On the Japanese side, the Producer Price Index (PPI) surged 4.9% year-over-year in April, significantly above the consensus estimate of 3% and the previous reading of 2.6%. This jump was attributed to rising oil and import costs linked to the Middle East conflict, adding to concerns about economic risks from Iran tensions and further pressuring the Yen [1]. Despite the sharp rise in PPI, which is typically seen as bullish for the JPY, the currency weakened due to broader market dynamics and risk sentiment. Speculation remains that Japanese authorities may intervene to support the Yen, which is capping further upside in the USD/JPY pair [1].
CONCLUSION
The Japanese Yen's decline to a two-week low against the US Dollar was driven by strong US economic data, rising Japanese wholesale inflation, and ongoing geopolitical risks. While the surge in Japan's PPI could signal inflationary pressures, market sentiment remains bearish on the Yen amid expectations of a hawkish Fed and persistent global uncertainties. Intervention speculation is limiting further downside, but the market impact remains high.